ADDITIONAL EVIDENCE FOR THE AUGMENTED INDUCTION OF TUMOR-SPECIFIC RESISTANCE IN VACCINIA VIRUS-PRIMED MICE BY IMMUNIZATION WITH VACCINIA VIRUS-MODULATED SYNGENEIC TUMOR-CELLS

被引：0

作者：

UEDA, S ^{[1
]}

WAKAMIYA, N ^{[1
]}

WU, KS ^{[1
]}

KATO, S ^{[1
]}

FUJIWARA, H ^{[1
]}

HAMAOKA, T ^{[1
]}

机构：

[1] OSAKA UNIV,SCH MED,INST CANC RES,DEPT ONCOGENESIS,FUKUSHIMA KU,OSAKA 553,JAPAN

来源：

BIKEN JOURNAL | 1984年 / 27卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1 / 7

页数：7

共 50 条

[31] THE AUGMENTATION OF TUMOR-SPECIFIC IMMUNITY BY VIRUS HELP .1. DEMONSTRATION OF VACCINIA VIRUS-REACTIVE HELPER T-CELL ACTIVITY INVOLVED IN ENHANCED INDUCTION OF CYTO-TOXIC LYMPHOCYTE-T AND ANTIBODY-RESPONSES
FUJIWARA, H
SHIMIZU, Y
TAKAI, Y
WAKAMIYA, N
UEDA, S
KATO, S
HAMAOKA, T
EUROPEAN JOURNAL OF IMMUNOLOGY, 1984, 14 (02) : 171 - 175
[32] STUDIES OF CLONED FRIEND-ERYTHROLEUKEMIA TUMOR-CELLS - MODULATION OF THE TUMOR-SPECIFIC CYTOLYTIC LYMPHOCYTE-T RESPONSE BY INFECTIOUS FRIEND-VIRUS PRODUCTION INVITRO
PLATA, F
GOODENOW, MM
LILLY, F
JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 151 (03): : 726 - 742
[33] Tumor Specific T Cells Generated by Cytokine-Armed Oncolytic Vaccinia Virus Represent a New Therapeutic Strategy for Adoptive T Cell Transfer
Feist, Mathilde
Liu, Zuqiang
Giehl, Esther
Ma, Congrong
Kammula, Udai
Guo, Zong Sheng
Bartlett, David L.
MOLECULAR THERAPY, 2018, 26 (05) : 199 - 199
[34] MODIFICATION OF TUMOR-CELLS BY A LOW-DOSE OF NEWCASTLE-DISEASE VIRUS .3. POTENTIATION OF TUMOR-SPECIFIC CYTOLYTIC T-CELL ACTIVITY VIA INDUCTION OF INTERFERON-ALPHA-BETA
VONHOEGEN, P
ZAWATZKY, R
SCHIRRMACHER, V
CELLULAR IMMUNOLOGY, 1990, 126 (01) : 80 - 90
[35] TUMOR-SPECIFIC TRANSPLANTATION ANTIGEN ACTIVITY OF FRESHLY ADENOVIRUS-INFECTED CELLS - INTERCURRENT IMMUNIZATION AGAINST VIRAL TUMORIGENESIS WITH VIRUS-INFECTED CELLS
NAKAJIMA, S
HAMADA, C
UETAKE, H
JAPANESE JOURNAL OF MICROBIOLOGY, 1974, 18 (03): : 243 - 252
[36] IMMUNE-RESPONSES IN MICE TO TUMOR CHALLENGE AFTER IMMUNIZATION WITH NEWCASTLE-DISEASE VIRUS-INFECTED OR X-IRRADIATED TUMOR-CELLS OR CELL FRACTIONS
BEVERLEY, PC
LOWENTHAL, RM
TYRRELL, DAJ
INTERNATIONAL JOURNAL OF CANCER, 1973, 11 (01) : 212 - 223
[37] Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice
Bai, Ailin
Higham, Eileen
Eisen, Herman N.
Wittrup, K. Dane
Chen, Jianzhu
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (35) : 13003 - 13008
[38] MODIFICATION OF TUMOR-CELLS BY A LOW-DOSE OF NEWCASTLE-DISEASE VIRUS - AUGMENTATION OF THE TUMOR-SPECIFIC T-CELL RESPONSE IN THE ABSENCE OF AN ANTI-VIRAL RESPONSE
VONHOEGEN, P
WEBER, E
SCHIRRMACHER, V
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (08) : 1159 - 1166
[39] VACCINIA VIRUS-INFECTED C-C36 COLON-TUMOR CELL LYSATES STIMULATE CELLULAR-RESPONSES INVITRO AND PROTECT SYNGENEIC BALB/C MICE FROM TUMOR-CELL CHALLENGE
IWAKI, H
BARNAVON, Y
BASH, JA
WALLACK, MK
JOURNAL OF SURGICAL ONCOLOGY, 1989, 40 (02) : 90 - 96
[40] Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimen
Hodge, James W.
Higgins, Jack
Schlom, Jeffrey
VACCINE, 2009, 27 (33) : 4475 - 4482

← 1 2 3 4 5 →